[1]
2024. Efficacy Levels of Recombinant Tetravalent Dengue Vaccine (Cyd-Tdv) in Children Aged 2-16 Years: Meta-Analysis. JISIP (Jurnal Ilmu Sosial dan Pendidikan). 8, 3 (Jun. 2024), 1583–1591. DOI:https://doi.org/10.58258/jisip.v8i3.6988.